Factors affecting incorporation of drug into solid solution with HPMCP during solvent change co-precipitation

被引:35
作者
Sertsou, G
Butler, J
Scott, A
Hempenstall, J
Rades, T
机构
[1] Univ Otago, Sch Pharm, Formulat & Drug Delivery Grp, Dunedin, New Zealand
[2] GlaxoSmithKline, Pharmaceut Dev Dept, Ware, Herts, England
关键词
co-precipitation; solvent change; amorphous solid solution; poorly soluble drug; HPMCP; factorial study;
D O I
10.1016/S0378-5173(02)00331-9
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Drug-hydroxypropyl methylcellulose phthalate (HPMCP) mixtures were completely dissolved in acetone, and the resulting solution was added drop-wise into HCl(aq)). Resulting co-precipitates were filtered, and then dried under vacuum at 45 degreesC, -800 mbar for 24 h. Modulated differential scanning calorimetry, thermogravimetric analysis, X-ray powder diffraction and HPLC were used to detect and quantify different phases present in co-precipitates. A 1/8 factorial study followed by a circumscribed central composite (CCC) study of significant factors, were used to detect and quantify respectively. the effects that processing factors had on the percentage of drug present in co-precipitates which was incorporated into solid solution (the response). Robustness of the model obtained from the CCC study was tested. Statistically significant factors were found to be the percentage of drug added into solvent, stirrer speed, and antisolvent pH, The statistically significant mathematical model obtained from the CCC study predicted that the dominant factor influencing the response is the percentage of drug added into solvent. The effect of stirrer speed on the response includes a local maximum at stirrer speed approximate to 700 rpm, Both stirrer speed and antisolvent pH showed interactions with the percentage of drug added into solvent. The model obtained from this study indicated the possibility of two opposing phenomena influencing the response: crystallization inhibition by HPMCP, and solvent-antisolvent plasticization. Testing of this model using eight experimentally determined points showed reasonable robustness, with six out of eight points lying inside 95% prediction intervals. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:99 / 108
页数:10
相关论文
共 33 条
[1]
THE MOLECULAR-BASIS OF MOISTURE EFFECTS ON THE PHYSICAL AND CHEMICAL-STABILITY OF DRUGS IN THE SOLID-STATE [J].
AHLNECK, C ;
ZOGRAFI, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 62 (2-3) :87-95
[2]
A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]
AULTON ME, 1994, PHARM SCI DOSAGE FOR, P62
[4]
PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS - X-RAY-DIFFRACTION AND AQUEOUS SOLUBILITY STUDIES ON GRISEOFULVIN-POLYETHYLENE GLYCOL 6000 SYSTEMS [J].
CHIOU, WL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (07) :989-991
[5]
The mechanisms of drug release from solid dispersions in water-soluble polymers [J].
Craig, DQM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 231 (02) :131-144
[6]
Supercooled liquids and glasses [J].
Ediger, MD ;
Angell, CA ;
Nagel, SR .
JOURNAL OF PHYSICAL CHEMISTRY, 1996, 100 (31) :13200-13212
[7]
GREEN DW, 1984, PERRYS CHEM ENG HDB, P21
[8]
What is the true solubility advantage for amorphous pharmaceuticals? [J].
Hancock, BC ;
Parks, M .
PHARMACEUTICAL RESEARCH, 2000, 17 (04) :397-404
[9]
THE RELATIONSHIP BETWEEN THE GLASS-TRANSITION TEMPERATURE AND THE WATER-CONTENT OF AMORPHOUS PHARMACEUTICAL SOLIDS [J].
HANCOCK, BC ;
ZOGRAFI, G .
PHARMACEUTICAL RESEARCH, 1994, 11 (04) :471-477
[10]
Characteristics and significance of the amorphous state in pharmaceutical systems [J].
Hancock, BC ;
Zograf, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) :1-12